I won’t hazard a guess on SP reaction to EUA in Brazil, but it should have the hurling power of a good trebuchet. WSJ had an entertaining article years ago where people who built these things got together for a contest to see how far they could hurl over-sized pumpkins. I think we can get a 600 pound pumpkin to take out one of the ramparts of the big pharma fortress if it doesn’t explode first on launch from all those forces. That would be a start for Cytodyne!

Virtually instant revenue, no more raises, money problems vanish and lots of fuel in the boiler to ramp up trials on ohm20’s list. Another thing it would do is add credibility and new shareholder interest at a time bashers have flooded most message boards with visions of a ghost ship about to founder…die hard longs are holding us up but we need fresh investors to enter the hunt and swamp any short fuel….regulatory approval would do that. EUA and related revenue would certainly get us to a value that would get us uplisted and as the tutes board the train the share price will seek a level worthy of the molecule.